DrugWise Discovery ApS: Financial statements 2025
CVR: 43888862
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
DrugWise Discovery ApS (CVR 43888862) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 266,857 and a net result of DKK 208,161 compared with DKK 104,809 the year before. That is an increase of 97.3% compared with the year before. Equity in the 2025 report amounted to DKK 575,081. The solvency ratio was 68.7%.
- Gross Profit
- DKK 266,857
- Profit/Loss
- DKK 208,161
- Equity
- DKK 575,081
- Total Assets
- DKK 837,133
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 267K | 208K | 575K | 0 |
| 2024 | - | 135K | 105K | 367K | 0 |
| 2023 | - | 287K | 223K | 263K | 0 |
Official annual report
How creditworthy is DrugWise Discovery ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
DrugWise Discovery ApS has published its annual report for 2024. Gross profit came to DKK 135,247, and the net result was DKK 104,809.
About DrugWise Discovery ApS
DrugWise Discovery ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2023. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Samra Joke Sanni. The company is owned by NSSK Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 266,857 and a net result of DKK 208,161 compared with DKK 104,809 the year before. Equity in the 2025 report amounted to DKK 575,081.